These compounds may interact with:
Fibroblast growth factor receptor 1
Potentially involved in: intellectual disability; pfeiffer syndrome; klinefelter's syndrome; craniosynostosis; kallmann syndrome; holoprosencephaly; breast cancer; kidney cancer; carcinoma; lipomatosis; hypogonadism; acrocephalosyndactylia; cancer; hypereosinophilic syndrome; cleft lip; cleft palate; cryptorchidism; mastocytosis; achondroplasia; congenital myasthenic syndrome 6
Disease data sourced from Pharos.